MORC3/NXP2 is a nuclear matrix and PML nuclear body-associated MORC-family GHKL/HATPase protein with a CW-type zinc finger that reads methylated H3K4. It functions as a SUMO-regulated chromatin/PML-body scaffold and ATPase involved in intrinsic antiviral restriction, chromatin-associated repression, recruitment/maintenance of nuclear restriction factors, and negative regulation of interferon-beta programs.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005634
nucleus
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: MORC3 is a nuclear/nuclear-matrix protein and PML nuclear body component.
Reason: Nuclear localization is strongly supported, although more specific PML body and nuclear matrix terms should also be retained.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
file:human/MORC3/MORC3-deep-research-falcon.md
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
|
|
GO:0140002
histone H3K4me3 reader activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: The MORC3 CW-type zinc finger is reported to bind methylated H3K4.
Reason: Histone H3K4me3 reader activity is consistent with the CW-domain evidence and chromatin-associated function.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
|
|
GO:0140374
antiviral innate immune response
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: MORC3 contributes to intrinsic antiviral restriction, including PML-body-associated restriction of HSV-1 and HCMV.
Reason: Antiviral innate immune response is a supported major function of MORC3.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0016605
PML body
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: MORC3 localizes to PML nuclear bodies through SUMO/SIM-dependent interactions and helps recruit restriction factors there.
Reason: PML body localization is one of the best-supported cellular component annotations for MORC3.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
file:human/MORC3/MORC3-deep-research-falcon.md
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
|
|
GO:0006325
chromatin organization
|
IEA
GO_REF:0000108 |
ACCEPT |
Summary: MORC3 is a chromatin-associated ATPase/scaffold implicated in epigenetic repression and chromatin organization.
Reason: Chromatin organization is supported by conserved MORC3 mechanism and by MORC3-mediated repression of viral/foreign DNA and interferon programs.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains; ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et al., *Nat Commun* (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
|
|
GO:0002376
immune system process
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: MORC3 has immune functions, but the evidence supports the more specific antiviral innate immune response and interferon-beta regulatory terms.
Reason: Use antiviral innate immune response rather than the broad parent immune system process.
Proposed replacements:
antiviral innate immune response
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0003723
RNA binding
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: The curated MORC3 literature supports ATPase, CW histone-reader, chromatin/PML-body scaffold, and antiviral restriction roles, not direct RNA binding.
Reason: This electronically inferred RNA-binding annotation is not supported by the gene-specific functional synthesis.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
|
|
GO:0005654
nucleoplasm
|
IEA
GO_REF:0000120 |
MODIFY |
Summary: MORC3 is nuclear, but the more specific supported locations are PML bodies and nuclear matrix/chromatin-associated nuclear structures.
Reason: Use PML body and nuclear matrix instead of broad nucleoplasm when curating MORC3 localization.
Proposed replacements:
PML body
nuclear matrix
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
file:human/MORC3/MORC3-deep-research-falcon.md
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
|
|
GO:0005694
chromosome
|
IEA
GO_REF:0000044 |
MODIFY |
Summary: MORC3 is chromatin-associated, but chromosome is a broad location for this evidence.
Reason: Use chromatin to represent the supported chromosome-associated localization/function more precisely.
Proposed replacements:
chromatin
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains; ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et al., *Nat Commun* (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
|
|
GO:0008270
zinc ion binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: MORC3 contains a CW-type zinc finger domain.
Reason: Zinc ion binding is supported by the CW zinc-finger domain architecture.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
|
|
GO:0016363
nuclear matrix
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: MORC3/NXP2 is consistently characterized as a nuclear matrix protein.
Reason: Nuclear matrix localization is supported by the literature synthesis.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
|
|
GO:0016605
PML body
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: MORC3 localizes to PML nuclear bodies through SUMO/SIM-dependent interactions and helps recruit restriction factors there.
Reason: PML body localization is one of the best-supported cellular component annotations for MORC3.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
file:human/MORC3/MORC3-deep-research-falcon.md
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
|
|
GO:0016887
ATP hydrolysis activity
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: MORC3 is a MORC-family GHKL/HATPase ATPase, and ATPase activity is required for PML-body localization/recruitment functions.
Reason: ATP hydrolysis activity is a core molecular feature of MORC3.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
|
|
GO:0045087
innate immune response
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: MORC3 participates in innate immunity, but the evidence is specifically antiviral restriction and interferon regulation.
Reason: Use antiviral innate immune response for the supported immune role.
Proposed replacements:
antiviral innate immune response
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0046872
metal ion binding
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: MORC3 metal binding is specifically attributable to its CW-type zinc finger.
Reason: Use zinc ion binding rather than generic metal ion binding.
Proposed replacements:
zinc ion binding
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
|
|
GO:0140002
histone H3K4me3 reader activity
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: The MORC3 CW-type zinc finger is reported to bind methylated H3K4.
Reason: Histone H3K4me3 reader activity is consistent with the CW-domain evidence and chromatin-associated function.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
|
|
GO:0005515
protein binding
|
IPI
PMID:26496610 A human interactome in three quantitative dimensions organiz... |
MARK AS OVER ANNOTATED |
Summary: MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding is not informative.
Reason: The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin organization, and antiviral restriction.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0005515
protein binding
|
IPI
PMID:27173435 An organelle-specific protein landscape identifies novel dis... |
MARK AS OVER ANNOTATED |
Summary: MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding is not informative.
Reason: The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin organization, and antiviral restriction.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding is not informative.
Reason: The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin organization, and antiviral restriction.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding is not informative.
Reason: The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin organization, and antiviral restriction.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0005515
protein binding
|
IPI
PMID:35271311 OpenCell: Endogenous tagging for the cartography of human ce... |
MARK AS OVER ANNOTATED |
Summary: MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding is not informative.
Reason: The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin organization, and antiviral restriction.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0005515
protein binding
|
IPI
PMID:35914814 Chr21 protein-protein interactions: enrichment in proteins i... |
MARK AS OVER ANNOTATED |
Summary: MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding is not informative.
Reason: The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin organization, and antiviral restriction.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0005515
protein binding
|
IPI
PMID:40205054 Multimodal cell maps as a foundation for structural and func... |
MARK AS OVER ANNOTATED |
Summary: MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding is not informative.
Reason: The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin organization, and antiviral restriction.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: MORC3 is a nuclear/nuclear-matrix protein and PML nuclear body component.
Reason: Nuclear localization is strongly supported, although more specific PML body and nuclear matrix terms should also be retained.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
file:human/MORC3/MORC3-deep-research-falcon.md
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
|
|
GO:0005654
nucleoplasm
|
IDA
GO_REF:0000052 |
MODIFY |
Summary: MORC3 is nuclear, but the more specific supported locations are PML bodies and nuclear matrix/chromatin-associated nuclear structures.
Reason: Use PML body and nuclear matrix instead of broad nucleoplasm when curating MORC3 localization.
Proposed replacements:
PML body
nuclear matrix
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
file:human/MORC3/MORC3-deep-research-falcon.md
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
|
|
GO:0140002
histone H3K4me3 reader activity
|
IDA
PMID:26933034 Family-wide Characterization of Histone Binding Abilities of... |
ACCEPT |
Summary: The MORC3 CW-type zinc finger is reported to bind methylated H3K4.
Reason: Histone H3K4me3 reader activity is consistent with the CW-domain evidence and chromatin-associated function.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
|
|
GO:0000122
negative regulation of transcription by RNA polymerase II
|
IDA
PMID:34759314 Self-guarding of MORC3 enables virulence factor-triggered im... |
ACCEPT |
Summary: MORC3 contributes to repression of transcriptional programs, including IFNB1/interferon-linked gene regulation and foreign DNA silencing.
Reason: Negative regulation of RNA polymerase II transcription is consistent with the MORC3 chromatin repression evidence.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Intrinsic immunity and interferon pathway modulation.** In OSCC/HNSCC models, MORC3 knockdown upregulated interferon-associated genes and increased STAT1 and PD-L1, suggesting MORC3 suppresses interferon-driven transcriptional programs in this context (fu2024genomewideanalysisreveals pages 3-7). In myositis/cancer-associated myositis literature, MORC3 is described as an antiviral factor and a repressor of IFNB1 (patasova2023geneticinfluencesin pages 6-8). Together, these suggest MORC3 contributes to a chromatin-based brake on interferon gene expression, with context-dependent consequences (antiviral restriction in fibroblast/hepatocyte models vs immune evasion phenotypes in cancer).
file:human/MORC3/MORC3-deep-research-falcon.md
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains; ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et al., *Nat Commun* (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
|
|
GO:0000785
chromatin
|
IDA
PMID:34759314 Self-guarding of MORC3 enables virulence factor-triggered im... |
ACCEPT |
Summary: MORC3 is a chromatin-associated ATPase/scaffold with roles in repressive chromatin states.
Reason: Chromatin localization/function is supported by the mechanistic synthesis.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains; ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et al., *Nat Commun* (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
|
|
GO:0003677
DNA binding
|
IDA
PMID:34759314 Self-guarding of MORC3 enables virulence factor-triggered im... |
MARK AS OVER ANNOTATED |
Summary: MORC3 regulates chromatin/DNA elements, but available synthesized evidence supports chromatin association and MRE regulation rather than a clearly separable direct DNA-binding MF.
Reason: Curate the supported chromatin and transcription-regulatory roles instead of broad DNA binding unless direct DNA-binding evidence is reviewed in detail.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Intrinsic immunity and interferon pathway modulation.** In OSCC/HNSCC models, MORC3 knockdown upregulated interferon-associated genes and increased STAT1 and PD-L1, suggesting MORC3 suppresses interferon-driven transcriptional programs in this context (fu2024genomewideanalysisreveals pages 3-7). In myositis/cancer-associated myositis literature, MORC3 is described as an antiviral factor and a repressor of IFNB1 (patasova2023geneticinfluencesin pages 6-8). Together, these suggest MORC3 contributes to a chromatin-based brake on interferon gene expression, with context-dependent consequences (antiviral restriction in fibroblast/hepatocyte models vs immune evasion phenotypes in cancer).
file:human/MORC3/MORC3-deep-research-falcon.md
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains; ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et al., *Nat Commun* (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
|
|
GO:0016605
PML body
|
IDA
PMID:27440897 MORC3, a Component of PML Nuclear Bodies, Has a Role in Rest... |
ACCEPT |
Summary: MORC3 localizes to PML nuclear bodies through SUMO/SIM-dependent interactions and helps recruit restriction factors there.
Reason: PML body localization is one of the best-supported cellular component annotations for MORC3.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
file:human/MORC3/MORC3-deep-research-falcon.md
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
|
|
GO:0030674
protein-macromolecule adaptor activity
|
IDA
PMID:27440897 MORC3, a Component of PML Nuclear Bodies, Has a Role in Rest... |
ACCEPT |
Summary: MORC3 functions as a SUMO-regulated scaffold/adaptor for PML-body and viral-genome-associated restriction factors.
Reason: Protein-macromolecule adaptor activity is supported by MORC3-dependent recruitment of PML, Sp100, hDaxx, gamma-H2AX, p53, and related nuclear factors.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
|
|
GO:0032688
negative regulation of interferon-beta production
|
IDA
PMID:34759314 Self-guarding of MORC3 enables virulence factor-triggered im... |
ACCEPT |
Summary: Loss or degradation of MORC3 derepresses IFNB1/interferon programs, supporting a negative regulatory role.
Reason: Negative regulation of interferon-beta production is directly aligned with MORC3-mediated IFNB1 repression.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**Intrinsic immunity and interferon pathway modulation.** In OSCC/HNSCC models, MORC3 knockdown upregulated interferon-associated genes and increased STAT1 and PD-L1, suggesting MORC3 suppresses interferon-driven transcriptional programs in this context (fu2024genomewideanalysisreveals pages 3-7). In myositis/cancer-associated myositis literature, MORC3 is described as an antiviral factor and a repressor of IFNB1 (patasova2023geneticinfluencesin pages 6-8). Together, these suggest MORC3 contributes to a chromatin-based brake on interferon gene expression, with context-dependent consequences (antiviral restriction in fibroblast/hepatocyte models vs immune evasion phenotypes in cancer).
|
|
GO:0140374
antiviral innate immune response
|
IDA
PMID:27440897 MORC3, a Component of PML Nuclear Bodies, Has a Role in Rest... |
ACCEPT |
Summary: MORC3 contributes to intrinsic antiviral restriction, including PML-body-associated restriction of HSV-1 and HCMV.
Reason: Antiviral innate immune response is a supported major function of MORC3.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
file:human/MORC3/MORC3-deep-research-falcon.md
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
|
|
GO:2000774
positive regulation of cellular senescence
|
IDA
PMID:17332504 Dynamic regulation of p53 subnuclear localization and senesc... |
KEEP AS NON CORE |
Summary: MORC3 can activate p53 and induce cellular senescence in fibroblast models.
Reason: The p53/senescence phenotype is supported but is a downstream context-specific outcome of MORC3 PML-body localization and scaffold activity rather than the core conserved function.
Supporting Evidence:
PMID:17332504
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
file:human/MORC3/MORC3-deep-research-falcon.md
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
|
|
GO:0006468
protein phosphorylation
|
IDA
PMID:17332504 Dynamic regulation of p53 subnuclear localization and senesc... |
REMOVE |
Summary: MORC3 is a GHKL ATPase, not a protein kinase; the p53 study states that genotoxic stress-induced p53 phosphorylation still occurs in Morc3-deficient fibroblasts.
Reason: This annotation misattributes phosphorylation catalysis to MORC3. MORC3 regulates p53 localization/activity downstream of phosphorylation through PML nuclear bodies.
Supporting Evidence:
PMID:17332504
phosphorylation and stabilization of p53 but barely increased its
PMID:17332504
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
|
|
GO:0016605
PML body
|
IDA
PMID:17332504 Dynamic regulation of p53 subnuclear localization and senesc... |
ACCEPT |
Summary: MORC3 localizes to PML nuclear bodies through SUMO/SIM-dependent interactions and helps recruit restriction factors there.
Reason: PML body localization is one of the best-supported cellular component annotations for MORC3.
Supporting Evidence:
file:human/MORC3/MORC3-deep-research-falcon.md
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
file:human/MORC3/MORC3-deep-research-falcon.md
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
file:human/MORC3/MORC3-deep-research-falcon.md
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
|
|
GO:0018105
peptidyl-serine phosphorylation
|
IDA
PMID:17332504 Dynamic regulation of p53 subnuclear localization and senesc... |
REMOVE |
Summary: MORC3 is not a serine/threonine kinase, and the p53 paper supports a localization/activity role rather than peptidyl-serine phosphorylation by MORC3.
Reason: The annotation incorrectly converts a p53 phosphorylation phenotype into MORC3 kinase activity.
Supporting Evidence:
PMID:17332504
phosphorylation and stabilization of p53 but barely increased its
PMID:17332504
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
file:human/MORC3/MORC3-deep-research-falcon.md
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules: (i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
|
|
GO:0048147
negative regulation of fibroblast proliferation
|
IDA
PMID:17332504 Dynamic regulation of p53 subnuclear localization and senesc... |
KEEP AS NON CORE |
Summary: MORC3-dependent p53 activation and cellular senescence in fibroblast models imply reduced fibroblast proliferation.
Reason: This is a supported context-specific p53/senescence phenotype rather than a core MORC3 molecular function.
Supporting Evidence:
PMID:17332504
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
file:human/MORC3/MORC3-deep-research-falcon.md
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
|
|
GO:0050821
protein stabilization
|
IDA
PMID:17332504 Dynamic regulation of p53 subnuclear localization and senesc... |
REMOVE |
Summary: The p53 study indicates that genotoxic stress-induced p53 stabilization still occurs in Morc3-deficient fibroblasts; MORC3 instead affects p53 localization and transcriptional activity.
Reason: Protein stabilization is not the supported MORC3 activity from this evidence.
Supporting Evidence:
PMID:17332504
phosphorylation and stabilization of p53 but barely increased its
PMID:17332504
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
|
|
GO:0051457
maintenance of protein location in nucleus
|
IDA
PMID:17332504 Dynamic regulation of p53 subnuclear localization and senesc... |
KEEP AS NON CORE |
Summary: MORC3 helps recruit/maintain p53, Sp100, and viral-genome-associated restriction factors in nuclear PML-body contexts.
Reason: Maintenance of nuclear protein location is supported as a scaffold/localization role, but is secondary to the core PML-body chromatin-adaptor function.
Supporting Evidence:
PMID:17332504
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
file:human/MORC3/MORC3-deep-research-falcon.md
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
|
|
GO:0051457
maintenance of protein location in nucleus
|
IMP
PMID:17332504 Dynamic regulation of p53 subnuclear localization and senesc... |
KEEP AS NON CORE |
Summary: MORC3 helps recruit/maintain p53, Sp100, and viral-genome-associated restriction factors in nuclear PML-body contexts.
Reason: Maintenance of nuclear protein location is supported as a scaffold/localization role, but is secondary to the core PML-body chromatin-adaptor function.
Supporting Evidence:
PMID:17332504
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
file:human/MORC3/MORC3-deep-research-falcon.md
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
|
Q: Which MORC3 activities in human cells require the ATPase domain, the CW H3K4me3-reader domain, SUMOylation/SIM interactions, or combinations of these modules?
Q: Does MORC3 directly bind specific DNA elements such as the IFNB1-adjacent MRE, or is repression mediated through chromatin-associated partner proteins?
Experiment: Rescue MORC3 knockout human cells with ATPase-dead, CW-domain, SUMOylation-defective, and SIM-interaction mutants, then measure PML-body localization, restriction-factor recruitment, IFNB1/MRE repression, and HSV-1/HCMV restriction.
Hypothesis: MORC3 antiviral and interferon-repressive functions require separable ATPase, chromatin-reader, and SUMO/PML-body interaction modules.
Experiment: Perform CUT&RUN/CUT&Tag or ChIP-seq for endogenous MORC3 together with DNA-binding-deficient and partner-recruitment mutants at IFNB1/MRE, viral episomes, and retroelement loci.
Hypothesis: MORC3 occupies repressed chromatin templates through a partner-dependent chromatin scaffold mechanism rather than generic sequence-independent DNA binding.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Target verification and naming. The UniProt accession Q14149 corresponds to human MORC family CW-type zinc finger protein 3 (MORC3), historically described as NXP2/nuclear matrix protein 2 and recognized as an autoantigen in dermatomyositis. Multiple primary and review sources explicitly use the combined name NXP2/MORC3, confirming that the literature discussed here matches the intended human protein (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
Domain architecture and biochemical capabilities. MORC3 is described as containing three conserved modules: (i) a GHKL/HATPase-like ATPase domain (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a CW-type zinc finger reported to bind methylated H3K4, and (iii) a coiled-coil region implicated in dimerization/oligomerization (sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as chromatin-associated ATPases that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent pages 3-5).
SUMO biology and PML nuclear bodies (PML-NBs/ND10). MORC3 is a SUMOylated nuclear matrix/PML nuclear body client protein. It associates with PML nuclear bodies through SUMO–SIM interactions (SUMO on one partner and a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with PML isoform I (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
Primary functional framing (current consensus from available evidence). Across experimental systems, MORC3 is best viewed as a nuclear, chromatin-associated ATPase and SUMO-regulated scaffold that:
1) contributes to PML nuclear body organization and intrinsic antiviral restriction, and
2) participates in epigenetic repression programs (including retroelement silencing and interferon program repression) likely through chromatin remodeling/assembly mechanisms.
These themes converge on the idea that MORC3 helps enforce repressive chromatin states on foreign or potentially deleterious nucleic acids (viral genomes, transgenes, retroelements) and modulates innate immune gene expression (sloan2016morc3acomponent pages 3-5, groh2021morc3silencesendogenous pages 10-11, fu2024genomewideanalysisreveals pages 3-7, OpenTargets Search: -MORC3).
A 2023 genome-scale CRISPR screening study identified MORC3 as a cellular factor that restricts transgene expression from recombinant adeno-associated virus (rAAV) vectors. MORC3 knockout improved transgene expression across multiple AAV serotypes, and also increased expression from other viral vectors (lentivirus and adenovirus). Importantly, the enhancement was also demonstrated in human primary cells, underscoring translational relevance for gene therapy optimization (OpenTargets Search: -MORC3).
Interpretation. This work connects MORC3 to a clinically relevant, real-world implementation problem: host-cell epigenetic silencing of therapeutic vectors. The association with SETDB1/HUSH-linked restriction pathways (also implicated in antiviral and retroelement silencing) supports a coherent model in which MORC3 contributes to chromatin-based repression of newly introduced DNA templates (OpenTargets Search: -MORC3).
A 2024 “genome-wide” study in head and neck/oral squamous cell carcinoma (HNSCC/OSCC) reported MORC3 as a repressor of PD-L1 expression and of interferon-associated gene programs. The study combined TCGA/GEPIA2 analyses, OSCC tissue microarray immunohistochemistry (48 OSCC vs 10 normal oral mucosa), siRNA knockdown in CAL27 cells, RNA-seq, qRT-PCR, western blot, and flow cytometry of PD-L1 surface expression (fu2024genomewideanalysisreveals pages 2-3, fu2024genomewideanalysisreveals pages 3-7).
Key reported results include:
- MORC3 downregulation in multiple cancers and lower MORC3 protein expression in OSCC relative to normal tissue (fu2024genomewideanalysisreveals pages 2-3, fu2024genomewideanalysisreveals pages 3-7).
- In male TCGA HNSCC patients, higher MORC3 expression was associated with longer survival (stratification sizes reported as high n=105 vs low n=262) (fu2024genomewideanalysisreveals pages 3-7).
- MORC3 knockdown induced interferon/ISG programs and increased STAT1 and PD-L1; RNA-seq after knockdown identified 270 differentially expressed genes (DEGs) (171 up, 99 down), with enrichment for interferon signaling and PD-1/PD-L1 checkpoint pathways; the study proposed an axis involving LINC00880 contributing to PD-L1 regulation (fu2024genomewideanalysisreveals pages 3-7).
Interpretation. This positions MORC3 as an upstream modulator of tumor-immune interactions through interferon-linked regulation of PD-L1. However, the work is in a specific tumor context, and further mechanistic dissection (e.g., direct chromatin binding at PD-L1 regulators) would be needed to generalize.
A 2023 review focusing on cancer-associated myositis summarizes anti-NXP2 antibodies (targeting MORC3/NXP2) as clinically meaningful biomarkers with prevalence and cancer association estimates. It reports:
- Anti-NXP2 occurs in ~22–25% of juvenile dermatomyositis and 1–17% of adult-onset dermatomyositis (patasova2023geneticinfluencesin pages 6-8).
- Anti-NXP2 is described as increasing cancer-associated myositis risk by ~30% in adult-onset dermatomyositis, and retrospective series are summarized in which malignant neoplasms were observed in 24–37.5% of anti-NXP2-positive adult patients (patasova2023geneticinfluencesin pages 6-8).
This review also frames MORC3 mechanistically as a MORC-family ATPase with nuclear matrix binding features, with roles in chromatin/epigenetic regulation, antiviral activity, and repression of IFNB1 (patasova2023geneticinfluencesin pages 6-8).
Interpretation. The clinical association literature is heterogeneous, and newer multicenter cohorts (not limited to 2023–2024 in the retrieved set) indicate that assay methodology can strongly influence apparent anti-NXP2 positivity rates and downstream phenotype associations; therefore, conclusions about cancer risk should be made with attention to the detection method and cohort structure (OpenTargets Search: -MORC3).
MORC3 is consistently characterized as a nuclear matrix protein that localizes to PML nuclear bodies. In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures (sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
Mechanistically, the association with PML-NBs is reported to occur via SUMO–SIM interaction with PML.I, and PML-NB localization/recruitment functions require a functional ATPase domain (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
In a SILAC proteomics study of HSV-1 infection, MORC3/NXP2 was identified as a SUMO2-modified nuclear matrix protein whose abundance decreased by approximately 5.6-fold during HSV-1 infection. Both SUMOylated and unmodified MORC3 were degraded during infection in an ICP0-dependent manner, consistent with ICP0 functioning as an E3 ubiquitin ligase targeting SUMOylated substrates to counter intrinsic immunity (sloan2016morc3acomponent pages 3-5).
Functional depletion experiments support MORC3 as a contributor to PML-NB–associated intrinsic restriction.
- MORC3 depletion increased plaque formation efficiency of ICP0-null HSV-1, and increased levels of viral proteins (e.g., ICP4, UL42) early after infection, consistent with loss of a restriction activity. In contrast, wild-type HSV-1 did not show similar dependence because ICP0 rapidly degrades MORC3 and other SUMO-linked restriction factors, thereby counteracting MORC3-mediated restriction (sloan2016morc3acomponent pages 13-15).
- MORC3 depletion also increased plaque formation efficiency of wild-type HCMV, consistent with MORC3 contributing to repression of DNA viruses (sloan2016morc3acomponent pages 13-15).
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML, γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
Direct mechanistic evidence for MORC3 in epigenetic silencing is strong in mouse embryonic stem cells and is likely informative for human MORC3 given conserved architecture.
- Morc3 was identified in a genome-wide sgRNA screen for endogenous retrovirus (ERV) silencing factors, and Morc3 knockout caused ERV derepression, reduced H3K9me3, and increased chromatin accessibility (groh2021morc3silencesendogenous pages 1-2).
- The mechanistic link to chromatin assembly is that Morc3 enables Daxx-mediated histone H3.3 incorporation, and Morc3 mutant proteins (defective in the ATPase cycle and/or SUMOylation) fail to interact effectively with Daxx. The interaction depends on Morc3 SUMOylation and Daxx SUMO binding (groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13).
Although these experiments are not in human cells, they provide a plausible mechanistic basis for human MORC3’s effects on viral genomes and foreign DNA templates, consistent with the 2023 AAV restriction-factor finding and with interferon-program repression in cancer models (OpenTargets Search: -MORC3, fu2024genomewideanalysisreveals pages 3-7).
SUMO–PML nuclear body pathway. MORC3 is SUMOylated and operates as a SUMO-regulated PML-NB client, with localization mediated by SUMO–SIM interaction with PML.I. This situates MORC3 within the broader PML-NB/SUMO pathway central to intrinsic immunity and nuclear quality control (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15).
Intrinsic immunity and interferon pathway modulation. In OSCC/HNSCC models, MORC3 knockdown upregulated interferon-associated genes and increased STAT1 and PD-L1, suggesting MORC3 suppresses interferon-driven transcriptional programs in this context (fu2024genomewideanalysisreveals pages 3-7). In myositis/cancer-associated myositis literature, MORC3 is described as an antiviral factor and a repressor of IFNB1 (patasova2023geneticinfluencesin pages 6-8). Together, these suggest MORC3 contributes to a chromatin-based brake on interferon gene expression, with context-dependent consequences (antiviral restriction in fibroblast/hepatocyte models vs immune evasion phenotypes in cancer).
Anti-NXP2 autoantibodies (targeting MORC3/NXP2) are used in clinical phenotyping and risk stratification of dermatomyositis. Recent synthesis reports prevalence of ~22–25% in juvenile DM and 1–17% in adult DM, and highlights associations with muscle disease severity and calcinosis (patasova2023geneticinfluencesin pages 6-8). These antibodies are also discussed in the context of cancer-associated myositis with summaries of retrospective malignancy proportions (24–37.5% in anti-NXP2-positive adults across certain series) and an estimated ~30% increase in cancer-associated myositis risk in adult DM (patasova2023geneticinfluencesin pages 6-8). These data support clinical utility but also underscore heterogeneity and the need for careful interpretation across cohorts.
Because MORC3 knockout increases rAAV and other vector transgene expression in human primary cells, MORC3 (and related epigenetic restriction factors) represent actionable targets for improving gene therapy efficacy through vector engineering or transient modulation of host restriction pathways (OpenTargets Search: -MORC3).
The 2024 head and neck cancer study suggests MORC3 acts as a negative regulator of PD-L1 and interferon programs, linking its expression level to survival and tumor immune signaling (fu2024genomewideanalysisreveals pages 3-7). This provides a hypothesis-generating direction for biomarker development and for combination strategies involving immune checkpoint modulation, though further validation in independent cohorts and mechanistic work is needed.
| Functional theme | Key mechanism | Experimental evidence type | Key quantitative/statistical points (if available) | Representative recent source with DOI/URL and publication month/year |
|---|---|---|---|---|
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., J Virol (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains; ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et al., Nat Commun (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
| Innate immunity / IFNB1 repression | Recent work positions MORC3 as a negative regulator of type I interferon programs: it represses IFNB1 and broader IFN-stimulated gene expression, consistent with SUMO- and ATPase-dependent chromatin repression. In cancer cells, MORC3 knockdown derepresses IFN-associated genes; reviews of cancer-associated myositis also summarize MORC3 as an antiviral factor and IFNB1 repressor. (patasova2023geneticinfluencesin pages 6-8, fu2024genomewideanalysisreveals pages 1-2, fu2024genomewideanalysisreveals pages 3-7) | RNAi knockdown, RNA-seq, qRT-PCR, pathway enrichment, single-cell correlation analyses; clinical-review synthesis | In CAL27 cells, MORC3 knockdown yielded 270 DEGs (171 up, 99 down) and increased expression of multiple IFN-related genes (including MX2, IFIT1/2, IRF7, IRF9, IFI44L, IFIH1); reviews report anti-NXP2 adult DM cancer risk elevation of ~30% and connect MORC3 to antiviral/IFNB1-repressive biology. (fu2024genomewideanalysisreveals pages 3-7, patasova2023geneticinfluencesin pages 6-8) | Fu et al., Front Cell Dev Biol (Sep 2024), DOI: 10.3389/fcell.2024.1410130, https://doi.org/10.3389/fcell.2024.1410130; Patasova et al., Arthritis Rheumatol (Dec 2023), DOI: 10.1002/art.42345, https://doi.org/10.1002/art.42345 |
| Cancer / PD-L1 regulation | In head and neck/oral squamous cancer, MORC3 acts as a transcriptional repressor of immune-evasion pathways: knockdown increases STAT1 and PD-L1 and induces IFN-associated programs; LINC00880 contributes to this PD-L1 upregulation. MORC3 expression is broadly reduced in multiple cancers and higher expression is associated with better survival in HNSCC analyses. (fu2024genomewideanalysisreveals pages 2-3, fu2024genomewideanalysisreveals pages 1-2, fu2024genomewideanalysisreveals pages 3-7) | TCGA/GEPIA2 bioinformatics, RNA-seq after siRNA knockdown, qRT-PCR, western blot, flow cytometry, tissue microarray IHC, single-cell transcriptomics | Tissue microarray included 48 OSCC and 10 normal oral mucosa samples; survival comparison reported high MORC3 expression (n=105) vs low (n=262) in male TCGA HNSCC; MORC3 knockdown increased STAT1 and PD-L1 and promoted proliferation. (fu2024genomewideanalysisreveals pages 2-3, fu2024genomewideanalysisreveals pages 3-7) | Fu et al., Front Cell Dev Biol (Sep 2024), DOI: 10.3389/fcell.2024.1410130, https://doi.org/10.3389/fcell.2024.1410130 |
| Biomarker / anti-NXP2 autoantibodies in myositis | MORC3/NXP2 is a clinically important autoantigen in idiopathic inflammatory myopathies, especially dermatomyositis. Anti-NXP2 antibodies are used as serologic biomarkers associated with dermatomyositis, severe muscle disease/calcinosis, dysphagia in some cohorts, and possible cancer association in adults; assay methodology matters because line blot may overcall positivity relative to immunoprecipitation. (patasova2023geneticinfluencesin pages 6-8, OpenTargets Search: -MORC3) | Multicenter serology studies, immunoprecipitation, line blot, IP-Western, clinical correlation studies, review synthesis | Anti-NXP2 reported in ~22–25% of juvenile DM and 1–17% of adult-onset DM; retrospective adult series found malignancy in 24–37.5% of anti-NXP2-positive adults; in an Italian multicenter study, 60 line-blot-positive patients were analyzed, but IP confirmed 31/52 available sera (62%); anti-NXP2 positivity was associated with younger onset and more dermatomyositis, while cancer risk was similar to NXP2-negative myositis in that cohort. (patasova2023geneticinfluencesin pages 6-8, OpenTargets Search: -MORC3) | Patasova et al., Arthritis Rheumatol (Dec 2023), DOI: 10.1002/art.42345, https://doi.org/10.1002/art.42345; Fredi et al., Clin Rev Allergy Immunol (Jan 2022), DOI: 10.1007/s12016-021-08920-y, https://doi.org/10.1007/s12016-021-08920-y |
| Gene therapy relevance / restriction of transgene expression | MORC3 functions as a cellular restriction factor that suppresses expression from recombinant AAV and other viral vectors, likely via chromatin-based silencing pathways overlapping with SETDB1-linked repression. This gives MORC3 translational relevance in vector engineering and gene therapy optimization. (OpenTargets Search: -MORC3) | Genome-scale CRISPR screens, knockout validation in human cells and primary cells, transgene expression assays across vector serotypes | MORC3 knockout increased transgene expression from several AAV serotypes and also improved expression from lentiviral and adenoviral vectors; enhancement was observed in human primary cells, supporting physiological relevance. (OpenTargets Search: -MORC3) | Ngo & Puschnik, J Virol (Apr 2023), DOI: 10.1128/jvi.01948-22, https://doi.org/10.1128/jvi.01948-22 |
Table: This table summarizes the main experimentally supported functional annotations for human MORC3/NXP2, including nuclear-body biology, chromatin silencing, innate immune regulation, cancer relevance, biomarker use, and translational implications. It prioritizes recent 2023-2024 evidence where available and includes quantitative points and source details.
References
(sloan2016morc3acomponent pages 3-5): Elizabeth Sloan, Anne Orr, and Roger D. Everett. Morc3, a component of pml nuclear bodies, has a role in restricting herpes simplex virus 1 and human cytomegalovirus. Journal of Virology, 90:8621-8633, Oct 2016. URL: https://doi.org/10.1128/jvi.00621-16, doi:10.1128/jvi.00621-16. This article has 68 citations and is from a domain leading peer-reviewed journal.
(sloan2016morc3acomponent pages 13-15): Elizabeth Sloan, Anne Orr, and Roger D. Everett. Morc3, a component of pml nuclear bodies, has a role in restricting herpes simplex virus 1 and human cytomegalovirus. Journal of Virology, 90:8621-8633, Oct 2016. URL: https://doi.org/10.1128/jvi.00621-16, doi:10.1128/jvi.00621-16. This article has 68 citations and is from a domain leading peer-reviewed journal.
(groh2021morc3silencesendogenous pages 10-11): Sophia Groh, Anna Viktoria Milton, Lisa Katherina Marinelli, Cara V. Sickinger, Angela Russo, Heike Bollig, Gustavo Pereira de Almeida, Andreas Schmidt, Ignasi Forné, Axel Imhof, and Gunnar Schotta. Morc3 silences endogenous retroviruses by enabling daxx-mediated histone h3.3 incorporation. Nature Communications, Oct 2021. URL: https://doi.org/10.1038/s41467-021-26288-7, doi:10.1038/s41467-021-26288-7. This article has 60 citations and is from a highest quality peer-reviewed journal.
(fu2024genomewideanalysisreveals pages 3-7): Wenxuan Fu, Xiaomeng Chang, Kun Ye, Zige Zheng, Qianyi Lai, Minyang Ge, and Yan Shi. Genome-wide analysis reveals the morc3-mediated repression of pd-l1 expression in head and neck cancer. Frontiers in Cell and Developmental Biology, Sep 2024. URL: https://doi.org/10.3389/fcell.2024.1410130, doi:10.3389/fcell.2024.1410130. This article has 1 citations.
(OpenTargets Search: -MORC3): Open Targets Query (-MORC3, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(fu2024genomewideanalysisreveals pages 2-3): Wenxuan Fu, Xiaomeng Chang, Kun Ye, Zige Zheng, Qianyi Lai, Minyang Ge, and Yan Shi. Genome-wide analysis reveals the morc3-mediated repression of pd-l1 expression in head and neck cancer. Frontiers in Cell and Developmental Biology, Sep 2024. URL: https://doi.org/10.3389/fcell.2024.1410130, doi:10.3389/fcell.2024.1410130. This article has 1 citations.
(patasova2023geneticinfluencesin pages 6-8): Karina Patasova, Ingrid E. Lundberg, and Marie Holmqvist. Genetic influences in
(sloan2016morc3acomponent media 84630a9e): Elizabeth Sloan, Anne Orr, and Roger D. Everett. Morc3, a component of pml nuclear bodies, has a role in restricting herpes simplex virus 1 and human cytomegalovirus. Journal of Virology, 90:8621-8633, Oct 2016. URL: https://doi.org/10.1128/jvi.00621-16, doi:10.1128/jvi.00621-16. This article has 68 citations and is from a domain leading peer-reviewed journal.
(sloan2016morc3acomponent media 5b6c97c8): Elizabeth Sloan, Anne Orr, and Roger D. Everett. Morc3, a component of pml nuclear bodies, has a role in restricting herpes simplex virus 1 and human cytomegalovirus. Journal of Virology, 90:8621-8633, Oct 2016. URL: https://doi.org/10.1128/jvi.00621-16, doi:10.1128/jvi.00621-16. This article has 68 citations and is from a domain leading peer-reviewed journal.
(groh2021morc3silencesendogenous pages 1-2): Sophia Groh, Anna Viktoria Milton, Lisa Katherina Marinelli, Cara V. Sickinger, Angela Russo, Heike Bollig, Gustavo Pereira de Almeida, Andreas Schmidt, Ignasi Forné, Axel Imhof, and Gunnar Schotta. Morc3 silences endogenous retroviruses by enabling daxx-mediated histone h3.3 incorporation. Nature Communications, Oct 2021. URL: https://doi.org/10.1038/s41467-021-26288-7, doi:10.1038/s41467-021-26288-7. This article has 60 citations and is from a highest quality peer-reviewed journal.
(groh2020morc3silencesendogenous pages 10-13): Sophia Groh, Anna Viktoria Milton, Lisa Marinelli, Cara V. Sickinger, Heike Bollig, Gustavo Pereira de Almeida, Ignasi Forné, Andreas Schmidt, Axel Imhof, and Gunnar Schotta. Morc3 silences endogenous retroviruses by enabling daxx-mediated h3.3 incorporation. bioRxiv, Nov 2020. URL: https://doi.org/10.1101/2020.11.12.380204, doi:10.1101/2020.11.12.380204. This article has 2 citations.
(groh2020morc3silencesendogenous pages 7-10): Sophia Groh, Anna Viktoria Milton, Lisa Marinelli, Cara V. Sickinger, Heike Bollig, Gustavo Pereira de Almeida, Ignasi Forné, Andreas Schmidt, Axel Imhof, and Gunnar Schotta. Morc3 silences endogenous retroviruses by enabling daxx-mediated h3.3 incorporation. bioRxiv, Nov 2020. URL: https://doi.org/10.1101/2020.11.12.380204, doi:10.1101/2020.11.12.380204. This article has 2 citations.
(fu2024genomewideanalysisreveals pages 1-2): Wenxuan Fu, Xiaomeng Chang, Kun Ye, Zige Zheng, Qianyi Lai, Minyang Ge, and Yan Shi. Genome-wide analysis reveals the morc3-mediated repression of pd-l1 expression in head and neck cancer. Frontiers in Cell and Developmental Biology, Sep 2024. URL: https://doi.org/10.3389/fcell.2024.1410130, doi:10.3389/fcell.2024.1410130. This article has 1 citations.
id: Q14149
gene_symbol: MORC3
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
MORC3/NXP2 is a nuclear matrix and PML nuclear body-associated MORC-family GHKL/HATPase protein with a CW-type zinc finger
that reads methylated H3K4. It functions as a SUMO-regulated chromatin/PML-body scaffold and ATPase involved in intrinsic
antiviral restriction, chromatin-associated repression, recruitment/maintenance of nuclear restriction factors, and negative
regulation of interferon-beta programs.
existing_annotations:
- term:
id: GO:0005634
label: nucleus
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
MORC3 is a nuclear/nuclear-matrix protein and PML nuclear body component.
action: ACCEPT
reason: >-
Nuclear localization is strongly supported, although more specific PML body and nuclear matrix terms should also be
retained.
supported_by: &id001
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body
client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and
a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I**
(sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched
subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other
nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**.
In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures
(sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites
associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction
at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and
PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages
3-5, sloan2016morc3acomponent pages 13-15).
- term:
id: GO:0140002
label: histone H3K4me3 reader activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
The MORC3 CW-type zinc finger is reported to bind methylated H3K4.
action: ACCEPT
reason: >-
Histone H3K4me3 reader activity is consistent with the CW-domain evidence and chromatin-associated function.
supported_by: &id003
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules:
(i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type
zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization
(sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated
ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent
interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent
pages 3-5).
- term:
id: GO:0140374
label: antiviral innate immune response
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
MORC3 contributes to intrinsic antiviral restriction, including PML-body-associated restriction of HSV-1 and HCMV.
action: ACCEPT
reason: >-
Antiviral innate immune response is a supported major function of MORC3.
supported_by: &id002
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes
to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization
and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes
recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading
MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other
contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent
media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown,
viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3
depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque
formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages
3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol*
(Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML,
γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment
at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
- term:
id: GO:0016605
label: PML body
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
MORC3 localizes to PML nuclear bodies through SUMO/SIM-dependent interactions and helps recruit restriction factors
there.
action: ACCEPT
reason: >-
PML body localization is one of the best-supported cellular component annotations for MORC3.
supported_by: *id001
- term:
id: GO:0006325
label: chromatin organization
evidence_type: IEA
original_reference_id: GO_REF:0000108
review:
summary: >-
MORC3 is a chromatin-associated ATPase/scaffold implicated in epigenetic repression and chromatin organization.
action: ACCEPT
reason: >-
Chromatin organization is supported by conserved MORC3 mechanism and by MORC3-mediated repression of viral/foreign
DNA and interferon programs.
supported_by: &id004
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules:
(i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type
zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization
(sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated
ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent
interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains;
ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement
loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism
is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous
pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide
sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible
Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS
identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous
pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et
al., *Nat Commun* (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
- term:
id: GO:0002376
label: immune system process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
MORC3 has immune functions, but the evidence supports the more specific antiviral innate immune response and interferon-beta
regulatory terms.
action: MODIFY
reason: >-
Use antiviral innate immune response rather than the broad parent immune system process.
proposed_replacement_terms:
- id: GO:0140374
label: antiviral innate immune response
supported_by: *id002
- term:
id: GO:0003723
label: RNA binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
The curated MORC3 literature supports ATPase, CW histone-reader, chromatin/PML-body scaffold, and antiviral restriction
roles, not direct RNA binding.
action: REMOVE
reason: >-
This electronically inferred RNA-binding annotation is not supported by the gene-specific functional synthesis.
supported_by: *id003
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
MORC3 is nuclear, but the more specific supported locations are PML bodies and nuclear matrix/chromatin-associated
nuclear structures.
action: MODIFY
reason: >-
Use PML body and nuclear matrix instead of broad nucleoplasm when curating MORC3 localization.
proposed_replacement_terms:
- id: GO:0016605
label: PML body
- id: GO:0016363
label: nuclear matrix
supported_by: *id001
- term:
id: GO:0005694
label: chromosome
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
MORC3 is chromatin-associated, but chromosome is a broad location for this evidence.
action: MODIFY
reason: >-
Use chromatin to represent the supported chromosome-associated localization/function more precisely.
proposed_replacement_terms:
- id: GO:0000785
label: chromatin
supported_by: *id004
- term:
id: GO:0008270
label: zinc ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
MORC3 contains a CW-type zinc finger domain.
action: ACCEPT
reason: >-
Zinc ion binding is supported by the CW zinc-finger domain architecture.
supported_by: *id003
- term:
id: GO:0016363
label: nuclear matrix
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
MORC3/NXP2 is consistently characterized as a nuclear matrix protein.
action: ACCEPT
reason: >-
Nuclear matrix localization is supported by the literature synthesis.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
MORC3 is consistently characterized as a **nuclear matrix protein** that localizes to **PML nuclear bodies**.
In immunofluorescence microscopy, MORC3 colocalizes with the PML-NB component Sp100 in punctate nuclear structures
(sloan2016morc3acomponent media 84630a9e). During infection with HSV-1 lacking ICP0, MORC3 is recruited to sites
associated with incoming viral genomes (identified by ICP4 foci), consistent with a role in intrinsic restriction
at early stages of infection (sloan2016morc3acomponent media 5b6c97c8).
- term:
id: GO:0016605
label: PML body
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
MORC3 localizes to PML nuclear bodies through SUMO/SIM-dependent interactions and helps recruit restriction factors
there.
action: ACCEPT
reason: >-
PML body localization is one of the best-supported cellular component annotations for MORC3.
supported_by: *id001
- term:
id: GO:0016887
label: ATP hydrolysis activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
MORC3 is a MORC-family GHKL/HATPase ATPase, and ATPase activity is required for PML-body localization/recruitment
functions.
action: ACCEPT
reason: >-
ATP hydrolysis activity is a core molecular feature of MORC3.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules:
(i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type
zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization
(sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated
ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent
interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
Mechanistically, the association with PML-NBs is reported to occur via **SUMO–SIM interaction** with PML.I, and
PML-NB localization/recruitment functions require a **functional ATPase domain** (sloan2016morc3acomponent pages
3-5, sloan2016morc3acomponent pages 13-15).
- term:
id: GO:0045087
label: innate immune response
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
MORC3 participates in innate immunity, but the evidence is specifically antiviral restriction and interferon regulation.
action: MODIFY
reason: >-
Use antiviral innate immune response for the supported immune role.
proposed_replacement_terms:
- id: GO:0140374
label: antiviral innate immune response
supported_by: *id002
- term:
id: GO:0046872
label: metal ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
MORC3 metal binding is specifically attributable to its CW-type zinc finger.
action: MODIFY
reason: >-
Use zinc ion binding rather than generic metal ion binding.
proposed_replacement_terms:
- id: GO:0008270
label: zinc ion binding
supported_by: *id003
- term:
id: GO:0140002
label: histone H3K4me3 reader activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
The MORC3 CW-type zinc finger is reported to bind methylated H3K4.
action: ACCEPT
reason: >-
Histone H3K4me3 reader activity is consistent with the CW-domain evidence and chromatin-associated function.
supported_by: *id003
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26496610
review:
summary: >-
MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding
is not informative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin
organization, and antiviral restriction.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body
client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and
a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I**
(sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched
subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other
nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML,
γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment
at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:27173435
review:
summary: >-
MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding
is not informative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin
organization, and antiviral restriction.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body
client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and
a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I**
(sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched
subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other
nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML,
γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment
at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: >-
MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding
is not informative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin
organization, and antiviral restriction.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body
client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and
a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I**
(sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched
subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other
nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML,
γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment
at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
review:
summary: >-
MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding
is not informative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin
organization, and antiviral restriction.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body
client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and
a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I**
(sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched
subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other
nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML,
γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment
at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35271311
review:
summary: >-
MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding
is not informative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin
organization, and antiviral restriction.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body
client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and
a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I**
(sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched
subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other
nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML,
γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment
at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35914814
review:
summary: >-
MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding
is not informative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin
organization, and antiviral restriction.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body
client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and
a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I**
(sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched
subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other
nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML,
γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment
at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:40205054
review:
summary: >-
MORC3 has many protein partners in PML body, SUMO, chromatin, and interactome datasets, but generic protein binding
is not informative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The actionable biology is better represented by protein-macromolecule adaptor activity, PML body localization, chromatin
organization, and antiviral restriction.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body
client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and
a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I**
(sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched
subnuclear condensates and hubs for intrinsic immunity, DNA damage response, transcription regulation, and other
nuclear processes; MORC3 is one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML,
γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment
at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
MORC3 is a nuclear/nuclear-matrix protein and PML nuclear body component.
action: ACCEPT
reason: >-
Nuclear localization is strongly supported, although more specific PML body and nuclear matrix terms should also be
retained.
supported_by: *id001
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: >-
MORC3 is nuclear, but the more specific supported locations are PML bodies and nuclear matrix/chromatin-associated
nuclear structures.
action: MODIFY
reason: >-
Use PML body and nuclear matrix instead of broad nucleoplasm when curating MORC3 localization.
proposed_replacement_terms:
- id: GO:0016605
label: PML body
- id: GO:0016363
label: nuclear matrix
supported_by: *id001
- term:
id: GO:0140002
label: histone H3K4me3 reader activity
evidence_type: IDA
original_reference_id: PMID:26933034
review:
summary: >-
The MORC3 CW-type zinc finger is reported to bind methylated H3K4.
action: ACCEPT
reason: >-
Histone H3K4me3 reader activity is consistent with the CW-domain evidence and chromatin-associated function.
supported_by: *id003
- term:
id: GO:0000122
label: negative regulation of transcription by RNA polymerase II
evidence_type: IDA
original_reference_id: PMID:34759314
review:
summary: >-
MORC3 contributes to repression of transcriptional programs, including IFNB1/interferon-linked gene regulation and
foreign DNA silencing.
action: ACCEPT
reason: >-
Negative regulation of RNA polymerase II transcription is consistent with the MORC3 chromatin repression evidence.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Intrinsic immunity and interferon pathway modulation.** In OSCC/HNSCC models, MORC3 knockdown upregulated interferon-associated
genes and increased STAT1 and PD-L1, suggesting MORC3 suppresses interferon-driven transcriptional programs in
this context (fu2024genomewideanalysisreveals pages 3-7). In myositis/cancer-associated myositis literature, MORC3
is described as an antiviral factor and a repressor of IFNB1 (patasova2023geneticinfluencesin pages 6-8). Together,
these suggest MORC3 contributes to a chromatin-based brake on interferon gene expression, with context-dependent
consequences (antiviral restriction in fibroblast/hepatocyte models vs immune evasion phenotypes in cancer).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains;
ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement
loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism
is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous
pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide
sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible
Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS
identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous
pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et
al., *Nat Commun* (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
- term:
id: GO:0000785
label: chromatin
evidence_type: IDA
original_reference_id: PMID:34759314
review:
summary: >-
MORC3 is a chromatin-associated ATPase/scaffold with roles in repressive chromatin states.
action: ACCEPT
reason: >-
Chromatin localization/function is supported by the mechanistic synthesis.
supported_by: *id004
- term:
id: GO:0003677
label: DNA binding
evidence_type: IDA
original_reference_id: PMID:34759314
review:
summary: >-
MORC3 regulates chromatin/DNA elements, but available synthesized evidence supports chromatin association and MRE
regulation rather than a clearly separable direct DNA-binding MF.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Curate the supported chromatin and transcription-regulatory roles instead of broad DNA binding unless direct DNA-binding
evidence is reviewed in detail.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Intrinsic immunity and interferon pathway modulation.** In OSCC/HNSCC models, MORC3 knockdown upregulated interferon-associated
genes and increased STAT1 and PD-L1, suggesting MORC3 suppresses interferon-driven transcriptional programs in
this context (fu2024genomewideanalysisreveals pages 3-7). In myositis/cancer-associated myositis literature, MORC3
is described as an antiviral factor and a repressor of IFNB1 (patasova2023geneticinfluencesin pages 6-8). Together,
these suggest MORC3 contributes to a chromatin-based brake on interferon gene expression, with context-dependent
consequences (antiviral restriction in fibroblast/hepatocyte models vs immune evasion phenotypes in cancer).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains;
ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement
loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism
is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous
pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide
sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible
Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS
identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous
pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et
al., *Nat Commun* (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
- term:
id: GO:0016605
label: PML body
evidence_type: IDA
original_reference_id: PMID:27440897
review:
summary: >-
MORC3 localizes to PML nuclear bodies through SUMO/SIM-dependent interactions and helps recruit restriction factors
there.
action: ACCEPT
reason: >-
PML body localization is one of the best-supported cellular component annotations for MORC3.
supported_by: *id001
- term:
id: GO:0030674
label: protein-macromolecule adaptor activity
evidence_type: IDA
original_reference_id: PMID:27440897
review:
summary: >-
MORC3 functions as a SUMO-regulated scaffold/adaptor for PML-body and viral-genome-associated restriction factors.
action: ACCEPT
reason: >-
Protein-macromolecule adaptor activity is supported by MORC3-dependent recruitment of PML, Sp100, hDaxx, gamma-H2AX,
p53, and related nuclear factors.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
A notable mechanistic finding is that MORC3 depletion reduced recruitment of multiple factors (Sp100, hDaxx, PML,
γH2AX) to viral genomes, implying MORC3 participates in building/maintaining a restrictive chromatin environment
at incoming HSV-1 genomes (sloan2016morc3acomponent pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes
to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization
and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes
recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading
MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other
contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent
media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown,
viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3
depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque
formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages
3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol*
(Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
- term:
id: GO:0032688
label: negative regulation of interferon-beta production
evidence_type: IDA
original_reference_id: PMID:34759314
review:
summary: >-
Loss or degradation of MORC3 derepresses IFNB1/interferon programs, supporting a negative regulatory role.
action: ACCEPT
reason: >-
Negative regulation of interferon-beta production is directly aligned with MORC3-mediated IFNB1 repression.
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Intrinsic immunity and interferon pathway modulation.** In OSCC/HNSCC models, MORC3 knockdown upregulated interferon-associated
genes and increased STAT1 and PD-L1, suggesting MORC3 suppresses interferon-driven transcriptional programs in
this context (fu2024genomewideanalysisreveals pages 3-7). In myositis/cancer-associated myositis literature, MORC3
is described as an antiviral factor and a repressor of IFNB1 (patasova2023geneticinfluencesin pages 6-8). Together,
these suggest MORC3 contributes to a chromatin-based brake on interferon gene expression, with context-dependent
consequences (antiviral restriction in fibroblast/hepatocyte models vs immune evasion phenotypes in cancer).
- term:
id: GO:0140374
label: antiviral innate immune response
evidence_type: IDA
original_reference_id: PMID:27440897
review:
summary: >-
MORC3 contributes to intrinsic antiviral restriction, including PML-body-associated restriction of HSV-1 and HCMV.
action: ACCEPT
reason: >-
Antiviral innate immune response is a supported major function of MORC3.
supported_by: *id002
- term:
id: GO:2000774
label: positive regulation of cellular senescence
evidence_type: IDA
original_reference_id: PMID:17332504
review:
summary: >-
MORC3 can activate p53 and induce cellular senescence in fibroblast models.
action: KEEP_AS_NON_CORE
reason: >-
The p53/senescence phenotype is supported but is a downstream context-specific outcome of MORC3 PML-body localization
and scaffold activity rather than the core conserved function.
supported_by: &id006
- reference_id: PMID:17332504
supporting_text: >-
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes
to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization
and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes
recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading
MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other
contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent
media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown,
viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3
depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque
formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages
3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol*
(Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
- term:
id: GO:0006468
label: protein phosphorylation
evidence_type: IDA
original_reference_id: PMID:17332504
review:
summary: >-
MORC3 is a GHKL ATPase, not a protein kinase; the p53 study states that genotoxic stress-induced p53 phosphorylation
still occurs in Morc3-deficient fibroblasts.
action: REMOVE
reason: >-
This annotation misattributes phosphorylation catalysis to MORC3. MORC3 regulates p53 localization/activity downstream
of phosphorylation through PML nuclear bodies.
supported_by: &id005
- reference_id: PMID:17332504
supporting_text: >-
phosphorylation and stabilization of p53 but barely increased its
- reference_id: PMID:17332504
supporting_text: >-
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules:
(i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type
zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization
(sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated
ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent
interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent
pages 3-5).
- term:
id: GO:0016605
label: PML body
evidence_type: IDA
original_reference_id: PMID:17332504
review:
summary: >-
MORC3 localizes to PML nuclear bodies through SUMO/SIM-dependent interactions and helps recruit restriction factors
there.
action: ACCEPT
reason: >-
PML body localization is one of the best-supported cellular component annotations for MORC3.
supported_by: *id001
- term:
id: GO:0018105
label: peptidyl-serine phosphorylation
evidence_type: IDA
original_reference_id: PMID:17332504
review:
summary: >-
MORC3 is not a serine/threonine kinase, and the p53 paper supports a localization/activity role rather than peptidyl-serine
phosphorylation by MORC3.
action: REMOVE
reason: >-
The annotation incorrectly converts a p53 phosphorylation phenotype into MORC3 kinase activity.
supported_by: *id005
- term:
id: GO:0048147
label: negative regulation of fibroblast proliferation
evidence_type: IDA
original_reference_id: PMID:17332504
review:
summary: >-
MORC3-dependent p53 activation and cellular senescence in fibroblast models imply reduced fibroblast proliferation.
action: KEEP_AS_NON_CORE
reason: >-
This is a supported context-specific p53/senescence phenotype rather than a core MORC3 molecular function.
supported_by: *id006
- term:
id: GO:0050821
label: protein stabilization
evidence_type: IDA
original_reference_id: PMID:17332504
review:
summary: >-
The p53 study indicates that genotoxic stress-induced p53 stabilization still occurs in Morc3-deficient fibroblasts;
MORC3 instead affects p53 localization and transcriptional activity.
action: REMOVE
reason: >-
Protein stabilization is not the supported MORC3 activity from this evidence.
supported_by:
- reference_id: PMID:17332504
supporting_text: >-
phosphorylation and stabilization of p53 but barely increased its
- reference_id: PMID:17332504
supporting_text: >-
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
- term:
id: GO:0051457
label: maintenance of protein location in nucleus
evidence_type: IDA
original_reference_id: PMID:17332504
review:
summary: >-
MORC3 helps recruit/maintain p53, Sp100, and viral-genome-associated restriction factors in nuclear PML-body contexts.
action: KEEP_AS_NON_CORE
reason: >-
Maintenance of nuclear protein location is supported as a scaffold/localization role, but is secondary to the core
PML-body chromatin-adaptor function.
supported_by:
- reference_id: PMID:17332504
supporting_text: >-
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes
to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization
and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes
recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading
MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other
contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent
media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown,
viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3
depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque
formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages
3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol*
(Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
- term:
id: GO:0051457
label: maintenance of protein location in nucleus
evidence_type: IMP
original_reference_id: PMID:17332504
review:
summary: >-
MORC3 helps recruit/maintain p53, Sp100, and viral-genome-associated restriction factors in nuclear PML-body contexts.
action: KEEP_AS_NON_CORE
reason: >-
Maintenance of nuclear protein location is supported as a scaffold/localization role, but is secondary to the core
PML-body chromatin-adaptor function.
supported_by:
- reference_id: PMID:17332504
supporting_text: >-
Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes
to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization
and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes
recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading
MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other
contexts. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent
media 84630a9e) | SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown,
viral protein immunoblotting | MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3
depletion caused a marked increase in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque
formation; MORC3 colocalizes with PML-NB markers in punctate nuclear structures. (sloan2016morc3acomponent pages
3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol*
(Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16 |
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied
by conservative changes to GO terms applied by UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000108
title: Automatic assignment of GO terms using logical inference, based on on inter-ontology links
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:17332504
title: Dynamic regulation of p53 subnuclear localization and senescence by MORC3.
findings: []
- id: PMID:26496610
title: A human interactome in three quantitative dimensions organized by stoichiometries and abundances.
findings: []
- id: PMID:26933034
title: Family-wide Characterization of Histone Binding Abilities of Human CW Domain-containing Proteins.
findings: []
- id: PMID:27173435
title: An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.
findings: []
- id: PMID:27440897
title: MORC3, a Component of PML Nuclear Bodies, Has a Role in Restricting Herpes Simplex Virus 1 and Human
Cytomegalovirus.
findings: []
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
findings: []
- id: PMID:34759314
title: Self-guarding of MORC3 enables virulence factor-triggered immunity.
findings: []
- id: PMID:35271311
title: 'OpenCell: Endogenous tagging for the cartography of human cellular organization.'
findings: []
- id: PMID:35914814
title: 'Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset
Alzheimer''s disease.'
findings: []
- id: PMID:40205054
title: Multimodal cell maps as a foundation for structural and functional genomics.
findings: []
- id: file:human/MORC3/MORC3-deep-research-falcon.md
title: Falcon deep research on MORC3 function
findings:
- statement: MORC3 is a nuclear matrix and PML nuclear body protein with GHKL ATPase and CW zinc-finger domains.
- statement: MORC3 contributes to PML nuclear body-associated intrinsic antiviral restriction of HSV-1 and HCMV.
- statement: MORC3 acts as a chromatin-associated ATPase/scaffold involved in epigenetic repression and interferon
program regulation.
core_functions:
- molecular_function:
id: GO:0016887
label: ATP hydrolysis activity
description: >-
MORC3 is a MORC-family GHKL/HATPase chromatin-associated ATPase. Its ATPase cycle works with its CW zinc-finger chromatin-reader
module and SUMOylation to support repressive chromatin organization at foreign or deleterious DNA templates.
directly_involved_in:
- id: GO:0006325
label: chromatin organization
- id: GO:0000122
label: negative regulation of transcription by RNA polymerase II
locations:
- id: GO:0000785
label: chromatin
- id: GO:0016363
label: nuclear matrix
- id: GO:0005634
label: nucleus
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules:
(i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type
zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization
(sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated
ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent
interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent
pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| Epigenetic silencing / chromatin regulation | MORC3 is a GHKL ATPase with CW zinc finger and coiled-coil domains;
ATP binding/hydrolysis and SUMOylation enable interaction with DAXX and promote histone H3.3 deposition at retroelement
loci, supporting H3K9me3 heterochromatin and silencing. Although shown directly in mouse ES cells, the mechanism
is highly relevant to human MORC3 because the same domain architecture/function is conserved. (groh2021morc3silencesendogenous
pages 10-11, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Genome-wide
sgRNA screen, knockout/rescue mutants, ChIP-seq, ChIP-MS/IP-MS, ATAC-seq, H3.3 ChIP-qPCR, RT-qPCR | 2,737 reproducible
Morc3 ChIP peaks; Morc3 loss increased chromatin accessibility at 444 peaks and decreased it at 10 peaks; ChIP-MS
identified 489 Morc3-associated proteins; ATPase-cycle mutants failed to rescue ERV silencing. (groh2020morc3silencesendogenous
pages 7-10, groh2021morc3silencesendogenous pages 1-2, groh2020morc3silencesendogenous pages 10-13) | Groh et al.,
*Nat Commun* (Oct 2021), DOI: 10.1038/s41467-021-26288-7, https://doi.org/10.1038/s41467-021-26288-7 |
- molecular_function:
id: GO:0140002
label: histone H3K4me3 reader activity
description: >-
The MORC3 CW-type zinc finger recognizes methylated H3K4, connecting MORC3 to chromatin-reader activity in nuclear chromatin
contexts.
directly_involved_in:
- id: GO:0006325
label: chromatin organization
locations:
- id: GO:0000785
label: chromatin
- id: GO:0005634
label: nucleus
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Domain architecture and biochemical capabilities.** MORC3 is described as containing three conserved modules:
(i) a **GHKL/HATPase-like ATPase domain** (a “GHL ATPase”/GHKL-type ATPase in the MORC family), (ii) a **CW-type
zinc finger** reported to bind **methylated H3K4**, and (iii) a **coiled-coil** region implicated in dimerization/oligomerization
(sloan2016morc3acomponent pages 3-5). These features fit the concept of MORC proteins as **chromatin-associated
ATPases** that integrate ATPase-driven conformational changes with chromatin recognition (via CW) and multivalent
interactions (via coiled-coil) to regulate nuclear substructures and transcriptional states (sloan2016morc3acomponent
pages 3-5).
- molecular_function:
id: GO:0030674
label: protein-macromolecule adaptor activity
description: >-
MORC3 acts as a SUMO-regulated PML-body scaffold/adaptor that recruits and maintains nuclear restriction factors at
PML bodies and incoming viral genomes, contributing to antiviral restriction and interferon-beta regulatory programs.
directly_involved_in:
- id: GO:0140374
label: antiviral innate immune response
- id: GO:0032688
label: negative regulation of interferon-beta production
locations:
- id: GO:0016605
label: PML body
- id: GO:0016363
label: nuclear matrix
- id: GO:0005634
label: nucleus
supported_by:
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**SUMO biology and PML nuclear bodies (PML-NBs/ND10).** MORC3 is a **SUMOylated** nuclear matrix/PML nuclear body
client protein. It associates with PML nuclear bodies through **SUMO–SIM interactions** (SUMO on one partner and
a SUMO-interacting motif on the other), specifically reported as a SUMO–SIM interaction with **PML isoform I** (sloan2016morc3acomponent
pages 3-5, sloan2016morc3acomponent pages 13-15). PML nuclear bodies are SUMO-enriched subnuclear condensates and
hubs for intrinsic immunity, DNA damage response, transcription regulation, and other nuclear processes; MORC3 is
one of the SUMO-linked client proteins integrated into these assemblies (sloan2016morc3acomponent pages 3-5).
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
| PML nuclear bodies / viral restriction | Human MORC3 (NXP2) is a SUMOylated nuclear-matrix protein that localizes
to PML nuclear bodies via SUMO-SIM interactions with PML.I; its ATPase domain is required for PML-NB localization
and for recruiting Sp100/p53. During HSV-1 infection, MORC3 is recruited to incoming viral genomes and promotes
recruitment of intrinsic restriction factors (Sp100, hDaxx, PML, γH2AX). HSV-1 ICP0 counteracts this by degrading
MORC3. MORC3 also restricts HCMV, although influenza studies indicate virus-specific proviral effects in other contexts.
(sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15, sloan2016morc3acomponent media 84630a9e)
| SILAC/MS proteomics, colocalization microscopy, HSV-1 and HCMV plaque assays, shRNA knockdown, viral protein immunoblotting
| MORC3 abundance decreased ~5.6-fold during HSV-1 infection in proteomics; MORC3 depletion caused a marked increase
in plaque formation efficiency of ICP0-null HSV-1 and increased HCMV plaque formation; MORC3 colocalizes with PML-NB
markers in punctate nuclear structures. (sloan2016morc3acomponent pages 3-5, sloan2016morc3acomponent pages 13-15,
sloan2016morc3acomponent media 84630a9e) | Sloan et al., *J Virol* (Oct 2016), DOI: 10.1128/JVI.00621-16, https://doi.org/10.1128/JVI.00621-16
|
- reference_id: file:human/MORC3/MORC3-deep-research-falcon.md
supporting_text: >-
**Intrinsic immunity and interferon pathway modulation.** In OSCC/HNSCC models, MORC3 knockdown upregulated interferon-associated
genes and increased STAT1 and PD-L1, suggesting MORC3 suppresses interferon-driven transcriptional programs in this
context (fu2024genomewideanalysisreveals pages 3-7). In myositis/cancer-associated myositis literature, MORC3 is
described as an antiviral factor and a repressor of IFNB1 (patasova2023geneticinfluencesin pages 6-8). Together,
these suggest MORC3 contributes to a chromatin-based brake on interferon gene expression, with context-dependent
consequences (antiviral restriction in fibroblast/hepatocyte models vs immune evasion phenotypes in cancer).
proposed_new_terms: []
suggested_questions:
- question: >-
Which MORC3 activities in human cells require the ATPase domain, the CW H3K4me3-reader domain, SUMOylation/SIM interactions,
or combinations of these modules?
- question: >-
Does MORC3 directly bind specific DNA elements such as the IFNB1-adjacent MRE, or is repression mediated through chromatin-associated
partner proteins?
suggested_experiments:
- description: >-
Rescue MORC3 knockout human cells with ATPase-dead, CW-domain, SUMOylation-defective, and SIM-interaction mutants, then
measure PML-body localization, restriction-factor recruitment, IFNB1/MRE repression, and HSV-1/HCMV restriction.
hypothesis: >-
MORC3 antiviral and interferon-repressive functions require separable ATPase, chromatin-reader, and SUMO/PML-body interaction
modules.
- description: >-
Perform CUT&RUN/CUT&Tag or ChIP-seq for endogenous MORC3 together with DNA-binding-deficient and partner-recruitment
mutants at IFNB1/MRE, viral episomes, and retroelement loci.
hypothesis: >-
MORC3 occupies repressed chromatin templates through a partner-dependent chromatin scaffold mechanism rather than generic
sequence-independent DNA binding.